Bergapten is a natural compound with the potential to regenerate bone. However, its poor solubility and instability hinder its clinical use. We developed bergapten-loaded long-circulating liposomes (BP-LCL) to overcome these challenges. The liposomes were spherical, stable, and highly effective at delivering bergapten. We found that BP-LCL were biocompatible and enhanced the osteogenic differentiation of human dental pulp stem cells. It did this by increasing key markers like RUNX2, COL1, and OCN, and by activating the Wnt/β-catenin signaling pathway. This study suggested that BP-LCL could be a promising new approach for bone regeneration settings.
An iridoid glycoside, rhododeoside C (1), and a pyridine derivative, rhododeodine A (2), both previously undescribed, were isolated from the flowers of Rhododendron decorum. The structures were elucidated using 1D and 2D NMR spectroscopy, along with high-resolution electrospray ionization mass spectrometry (HRESIMS). The absolute configurations of both compounds were unambiguously assigned using electronic circular dichroism (ECD) computational methods. Furthermore, all isolated compounds were assessed for their cytotoxic activities against HepG2 and HeLa cell lines.
Matrine, a natural compound from traditional Chinese medicine, demonstrates anti-esophageal cancer (EC) efficacy via multi-target mechanisms. In this study, integrated network pharmacology and WGCNA identified MGLL, EPHX2, and CES2 as key targets for matrine. Clinical nomograms indicated their prognostic value, and bioinformatics analysis confirmed their downregulation in EC, correlating with tumor stage, survival, and immune infiltration. Molecular docking confirmed stable binding between matrine and these targets. In vitro experiments showed matrine upregulates their expressions, concurrently inhibiting EC cell proliferation and inducing apoptosis. In conclusion, matrine treats EC through dual actions-direct antitumor effects and immunomodulation-highlighting its therapeutic potential.
A new cyclohexenone, 5S-(3,4-dihydroxyphenethyl)cyclohex-2-en-1-one (1), along with two new phenanthrones, (4aS,10aS)- 1,9,10,10a -tetrahydro-4a,6,7-trihydroxy-4(4aH)-phenanthrone (2) and (4aS,10aS)-4a-hydroxy-7-methoxy-1,9,10,10a-tetrahydro-4(4aH)-phenanthrone 6-O-β-D-glucopyranoside (3) were isolated from the whole plant of Elatostema tenuicaudatum. The structures were determined by spectroscopic methods including 1D, 2D NMR and HR-ESI-MS. The absolute configurations of compounds 1-3 were determined by their experimental and calculated ECD spectral data. The isolates were evaluated for inhibitory activity on nitric oxide (NO) production in lipopolysaccharide (LPS)-activated RAW 264.7 macrophage cells, and compound 2 showed the strongest activity with an IC50 value of 9.5 ± 1.2 μM.

